Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), Due to the Potential for a Missing Label in the Batch | FDA

Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), Due to the Potential for a Missing Label in the Batch | FDA

Comments

Popular posts from this blog

Fresh Express Recalls Romaine-based Salads with Use-by Dates of May 13-16th Due to Possible Health Risk

$20,000 reward to find cabbie who dragged and killed man

Watershed Creation